Graybill Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-164,358
Closed -$1.95M 48
2017
Q2
$1.95M Sell
164,358
-902
-0.5% -$10.7K 1.54% 37
2017
Q1
$2.44M Buy
165,260
+2,620
+2% +$38.7K 1.94% 33
2016
Q4
$2.63M Buy
162,640
+13,685
+9% +$221K 2.25% 24
2016
Q3
$2.7M Sell
148,955
-1,095
-0.7% -$19.9K 2.51% 21
2016
Q2
$2.47M Buy
+150,050
New +$2.47M 2.29% 23